MedPath

The Effect of Mild Weight Loss on Circulating Metabolite Profiles

Not Applicable
Completed
Conditions
Weight Loss
Visceral Fat
Interventions
Behavioral: Control group
Behavioral: LCD group
Registration Number
NCT03135132
Lead Sponsor
Yonsei University
Brief Summary

To determine whether low calorie diet (LCD)-induced weight reduction caused changes in plasma metabolites and metabolic traits from baseline.

Detailed Description

Over a 12-week clinical intervention period, a randomized, controlled study was carried out; overweight subjects consumed a LCD (approximately 300kcal/d deficit, n=47) or a weight-maintenance diet (control, n=50) were included for analyzing plasma samples and metabolites using an ultra-performance liquid chromatography and mass spectrometry (UPLC-LTQ/Orbitrap MS).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Able to give informed consent
  • 20-65 years old
  • Males and females
  • Overweight (25.0 kg/m²≤ Body mass index <30 kg/m²)
  • Nondiabetic (Fasting glucose <126 mg/dL)
Read More
Exclusion Criteria
  • Unstable body weight (body weight change >1 kg within 3 months before screening)
  • Consumption of medication that affects body weight or energy expenditure
  • Pregnancy or breast-feeding
  • Hypertension, type 2 diabetes, cardiovascular disease, cerebrovascular disease, or thyroid disease
  • Liver disease, kidney disease, or gastrointestinal disease
  • Acute or chronic infections
  • Any acute or chronic disease requiring treatment
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control groupControl groupUsual dietary intake group
LCD groupLCD groupLow calorie diet (LCD) group (300kcal/day intake reduction)
Primary Outcome Measures
NameTimeMethod
Visceral fat area at L4 (CT)At 12-week follow-up
Change in visceral fat area at L4 from baselineAt baseline and 12-week follow-up
Putatively identified plasma metabolites (Normalized peak intensities)At 12-week follow-up
Changes in putatively identified plasma metabolites (Normalized peak intensities) from baselineAt baseline and 12-week follow-up
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Yonsei University

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath